Skip to main content
. 2017 Apr 20;10(3):385–395. doi: 10.1016/j.tranon.2017.03.002

Table 1.

Sample Demographics

Description N Gender (%Female) Mean Age (min-max)
T-stage M1 disease at dx 5 40 66 (44–85)
T1 < =1.00 mm 60 42 55 (28–84)
T2 = 1.01–2.00 mm 32 66 62 (31–88)
T3 = 2.01–4.00 mm 29 41 63 (24–88)
T4> 4.00 mm 17 29 63 (37–81)
Unclassified 6
Recurrence Yes 86 50 57 (28–84)
No 63 40 62 (24–88)
T-stage/Recurrence T1-T2/No recurrence 74 51 56 (28–84)
T3-T4/Recurrence 34 34 63 (24–88)
DFS 5 y Yes 91 49 58 (24–88)
No 58 40 61 (30–88)
Metastasis status at follow-up M1 at diagnosis 5 40 66 (44–85)
Metastasis 43 44 56 (24–82)
No metastasis 101 47 60 (28–88)
Location of the tumor Face 17 53 65 (31–88)
Lower part of body 41 73 57 (30–85)
Trunk 5 20 56 (29–84)
Upper part of body 82 32 60 (24–88)
Unclassified 4
Ulceration Yes 27 41 61 (30–84)
No 37 43 58 (28–88)
Unclassified 85

Sample demographics of the melanoma patients. DSF; Disease-free survival (5 years).